OVERVIEW

The seed of Symbiotec’s longstanding passion for pharmaceuticals was sown with the setting up of a laboratory in 1995, from then to now, we have remained true to the dream of offering quality APIs to ensure quality healthcare solutions and we hope to continue doing so even as we expand our reach.

  • 1995

    Set up of Laboratory for production of Cortico-Steroids APIs.

  • 2004

    Set up of Industrial scale Manufacturing Plant in Rau, Indore

  • 2008

    First EU GMP Certification of RAU Site.

  • 2009

    Successful US-FDA inspection of Rau Steroids API plant
    Commissioning of the SEZ unit
    Start of commercial production of

    • a) Cortico-Steroids
    • b) Steroid-Hormones APIs
  • 2011

    Commencement of fermentation activities from Biotech Facility at SEZ unit.
    Infusion of Capital by private equity ‘Franklin Tempelton’

  • 2012

    Accreditation by US-FDA SEZ site & Re-accreditation by US-FDA of Rau site

  • 2013

    Infusion of Capital by private equity ‘Actis’.
    Eu-GMP Certification of Sterile Manufacturing Facility, Rau Site and Eu-GMP Certification of SEZ Site.

  • 2014

    Re-Accreditation by US –FDA, Rau Site.

  • 2015

    Commencement of Large Scale Chemical Synthesis Plant in June 2015, with batch size up to 1000 Kg.

    • Re-Accreditation by US-FDA of SEZ Site.
    • Re-Qualification of Eu-GMP certification of RAU site and SEZ site.
  • 2017

    Re-accreditation by US – FDA

  • 2018

    Key Developments Re-Qualification of Eu-GMP certification of RAU Site and SEZ Site.
    Infusion of Capital by Private Equity, ‘Motilal Oswal Private Equity (MOPE)’ and ‘InvAscent’.

  • 2019

    Commissioning of a new corticosteroid block at Rau Unit

  • 2021

    Commissioning of a new sterile corticosteroid block at Rau Unit